Workup and Initial Management for Suspected IBD with Worsening Abdominal Pain
When inflammatory bowel disease is suspected in a patient with worsening abdominal pain, immediately perform ileocolonoscopy with biopsies from all segments combined with cross-sectional imaging (intestinal ultrasound or MR enterography) to establish diagnosis, assess disease extent, and rule out complications. 1
Diagnostic Workup Algorithm
Initial Laboratory Assessment
- Fecal calprotectin is your first-line biomarker with 88% sensitivity and 92% specificity at cutoff >50 μg/g for detecting IBD 1
- C-reactive protein (CRP) - though less sensitive than fecal calprotectin for disease activity
- Complete blood count, electrolytes, albumin, liver function tests 2
- Stool microbiology to exclude infectious colitis (do not delay treatment while awaiting results) 2
Endoscopic Evaluation
Perform full colonoscopy with terminal ileum intubation as the cornerstone diagnostic tool 1. Look for these specific patterns:
For Crohn's Disease:
- Skip lesions with rectal sparing
- Terminal ileum involvement
- Aphthous ulcers, deep ulcers, serpiginous ulcers
- Cobblestoning appearance 1
For Ulcerative Colitis:
- Diffuse continuous inflammation starting from anal canal
- Granularity, loss of vascular pattern, friability
- Superficial ulcerations
- Sharp demarcation line between normal and diseased mucosa 1
Obtain biopsies from all segments including normal-appearing mucosa for histopathologic confirmation 1
Cross-Sectional Imaging
Combine endoscopy with imaging on initial evaluation 1:
- Intestinal ultrasound (IUS): 95% diagnostic accuracy for established Crohn's disease when combining bowel wall thickness with color Doppler; sensitivity 95%, specificity 77% 1
- MR enterography (MRE): Detects small bowel disease and complications (strictures, fistulae, abscesses) 1
Critical caveat: Negative IUS in mild disease does not exclude IBD 1
If Initial Workup is Negative
Capsule endoscopy is recommended when clinical features suggest Crohn's disease but colonoscopy and imaging are negative 1
Severity Assessment Before Treatment
Assess disease location, pattern, and activity before initiating therapy 2:
- Location: ileal, ileocolonic, colonic, or other
- Pattern: inflammatory, stricturing, or fistulating
- Activity: mild, moderate, or severe
Rule out alternative explanations for symptoms beyond active inflammation 2:
- Bacterial overgrowth
- Bile salt malabsorption
- Fibrotic strictures causing obstruction
- Carbohydrate intolerance
- Septic complications (abscess)
Initial Management Based on Severity
For Suspected Crohn's Disease
Mild ileocolonic disease:
- High-dose mesalazine 4 g daily as initial therapy 2
Moderate to severe disease or failure of mesalazine:
- Prednisolone 40 mg daily orally, tapered gradually over 8 weeks 2
- Alternative: Budesonide 9 mg daily for isolated ileocecal disease (marginally less effective than prednisolone) 2
Severe disease requiring hospitalization:
- IV corticosteroids: hydrocortisone 400 mg/day OR methylprednisolone 60 mg/day 2, 3
- Concomitant IV metronidazole to distinguish active disease from septic complications 2
- Supportive care 3:
If obstructive symptoms present:
- Obtain plain abdominal radiograph 2
- Consider surgical consultation early 3
- IV corticosteroids only when active inflammation is confirmed 3
For Suspected Ulcerative Colitis
Severe disease (Truelove and Witts criteria):
- Immediate hospitalization 2
- Joint management with gastroenterologist AND colorectal surgeon from admission 2, 3
- IV methylprednisolone 60 mg daily 3
- Monitor response within 72 hours - prepare for rescue therapy if no improvement 3
- Daily monitoring: vital signs 4x daily, stool chart, abdominal exam for tenderness/rebound 2
- Labs every 24-48 hours: CBC, CRP, electrolytes, albumin 2
- Daily abdominal X-ray if colonic dilatation (transverse colon >5.5 cm) detected 2
- Counsel patient on 25-30% colectomy risk 2
Critical Pitfalls to Avoid
- Do not delay corticosteroids while awaiting stool microbiology in severe presentations 2
- Do not perform colonoscopy if toxic megacolon or perforation suspected - use imaging instead
- Do not rapidly taper steroids - this increases early relapse risk 2
- Do not miss complications: Always maintain low threshold for repeat imaging if clinical deterioration occurs 2
- Do not forget VTE prophylaxis - IBD patients have significantly elevated thromboembolism risk 2, 3
- Do not discharge until treatment response is stable with clear transition plan 3
The 2019 AGA guideline 4 emphasizes that in patients with persistent symptoms despite apparent remission, a stepwise approach ruling out ongoing inflammation (serial fecal calprotectin, repeat endoscopy, imaging) takes precedence before attributing symptoms to functional overlay.